The present invention relates to novel antiproliferative genes. More specifically,
isolated nucleic acid molecules are provided encoding the human B-cell translocation
genes 2 and 3 (BTG-2 and BTG-3). BTG-2 and BTG-3 polypeptides are also provided,
as are vectors, host cells and recombinant methods for producing the same.